Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,083 | 4 | 51.0% |
| Food and Beverage | $8,788 | 446 | 44.4% |
| Education | $906.01 | 16 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Olympus Corporation | $10,083 | 4 | $0 (2018) |
| Astellas Pharma US Inc | $1,949 | 74 | $0 (2024) |
| NeoTract Inc. | $1,139 | 53 | $0 (2020) |
| Janssen Biotech, Inc. | $907.40 | 43 | $0 (2019) |
| AbbVie Inc. | $827.51 | 62 | $0 (2020) |
| COLOPLAST CORP | $602.72 | 23 | $0 (2021) |
| Endo Pharmaceuticals Inc. | $444.84 | 21 | $0 (2020) |
| Amgen Inc. | $391.46 | 18 | $0 (2020) |
| PFIZER INC. | $356.84 | 23 | $0 (2020) |
| TOLMAR Pharmaceuticals, Inc. | $292.53 | 14 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $156.43 | 2 | Ferring Pharmaceuticals Inc. ($135.76) |
| 2023 | $23.94 | 1 | Tolmar, Inc. ($23.94) |
| 2022 | $54.30 | 3 | Teleflex LLC ($32.42) |
| 2021 | $279.73 | 7 | Astellas Pharma US Inc ($99.99) |
| 2020 | $1,382 | 74 | Astellas Pharma US Inc ($309.02) |
| 2019 | $2,676 | 127 | Astellas Pharma US Inc ($491.46) |
| 2018 | $7,093 | 153 | Olympus Corporation ($4,163) |
| 2017 | $8,112 | 99 | Olympus Corporation ($5,920) |
All Payment Transactions
466 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Oncology | ||||||
| 07/22/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $135.76 | General |
| Category: ONCOLOGY | ||||||
| 02/28/2023 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Prostate Cancer | ||||||
| 03/09/2022 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Interventional Urology | ||||||
| 02/04/2022 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Interventional Urology | ||||||
| 01/05/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: HYPERHYDROSIS | ||||||
| 12/20/2021 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Interventional Urology | ||||||
| 09/09/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: UROLOGY | ||||||
| 08/25/2021 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Interventional Urology | ||||||
| 07/01/2021 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $52.31 | General |
| Category: Men's Health | ||||||
| 06/28/2021 | COLOPLAST CORP | Torosa (Device) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Men's Health | ||||||
| 04/12/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 02/12/2021 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $46.81 | General |
| Category: Interventional Urology | ||||||
| 12/22/2020 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Interventional Urology | ||||||
| 12/14/2020 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $4.37 | General |
| Category: Interventional Urology | ||||||
| 11/11/2020 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Interventional Urology | ||||||
| 11/06/2020 | Acerus Pharmaceuticals Corporation | Natesto (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: Urology Endocrinology Men's Health | ||||||
| 11/03/2020 | Acerus Pharmaceuticals Corporation | Natesto (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Urology Endocrinology Men's Health | ||||||
| 10/30/2020 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Interventional Urology | ||||||
| 10/21/2020 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: UROLOGY | ||||||
| 10/13/2020 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: UROLOGY | ||||||
| 10/10/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2020 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 10/06/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.99 | General |
| 09/30/2020 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 3,506 | 7,743 | $2.1M | $332,706 |
| 2022 | 38 | 3,736 | 10,623 | $2.3M | $378,284 |
| 2021 | 40 | 3,970 | 7,988 | $2.3M | $412,493 |
| 2020 | 44 | 4,353 | 8,401 | $2.3M | $427,856 |
All Medicare Procedures & Services
164 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 629 | 795 | $307,509 | $53,538 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 494 | 549 | $298,854 | $50,356 | 16.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 194 | 248 | $273,122 | $46,981 | 17.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 267 | 267 | $207,192 | $31,596 | 15.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 24 | 194 | $122,780 | $26,242 | 21.4% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 316 | 343 | $127,840 | $15,522 | 12.1% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 28 | 34 | $89,736 | $14,889 | 16.6% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 16 | 16 | $54,528 | $9,222 | 16.9% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 46 | 46 | $54,274 | $8,559 | 15.8% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 74 | 75 | $66,912 | $7,999 | 12.0% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 13 | 3,200 | $28,800 | $7,032 | 24.4% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 17 | 17 | $34,492 | $5,722 | 16.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 53 | $29,031 | $5,429 | 18.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 38 | $28,974 | $5,003 | 17.3% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 118 | 124 | $50,536 | $4,752 | 9.4% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 14 | 64 | $37,696 | $4,407 | 11.7% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 17 | 17 | $34,646 | $4,311 | 12.4% |
| 55874 | Injection of biodegradable material next to prostate | Facility | 2023 | 28 | 28 | $18,910 | $3,670 | 19.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 360 | 398 | $64,368 | $3,266 | 5.1% |
| 51705 | Simple change of bladder tube | Office | 2023 | 13 | 43 | $18,421 | $3,155 | 17.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $20,397 | $3,137 | 15.4% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 21 | 61 | $21,045 | $2,791 | 13.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $14,768 | $2,257 | 15.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 56 | 56 | $13,652 | $2,140 | 15.7% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 16 | 17 | $27,360 | $1,547 | 5.7% |
About Dr. Mark Laspina, D.O
Dr. Mark Laspina, D.O is a Urology healthcare provider based in Salem, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1114181054.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Laspina, D.O has received a total of $19,777 in payments from pharmaceutical and medical device companies, with $156.43 received in 2024. These payments were reported across 466 transactions from 42 companies. The most common payment nature is "Consulting Fee" ($10,083).
As a Medicare-enrolled provider, Laspina has provided services to 15,565 Medicare beneficiaries, totaling 34,755 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 164 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Salem, MA
- Active Since 07/10/2008
- Last Updated 06/18/2010
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1114181054
Products in Payments
- XTANDI (Drug) $1,312
- UroLift (Device) $794.95
- Erleada (Drug) $670.18
- XIAFLEX (Biological) $349.92
- Urolift - UL400 (Device) $343.87
- ZYTIGA (Drug) $328.12
- ELIGARD (Drug) $316.47
- Myrbetriq (Drug) $313.19
- Androgel (Drug) $291.17
- Noctiva (Drug) $247.31
- Prolia (Biological) $237.81
- Lupron Depot (Drug) $227.82
- TITAN (Device) $215.45
- MYRBETRIQ (Drug) $203.81
- Natesto (Drug) $185.82
- LUPRON DEPOT (Drug) $162.43
- LoFric (Device) $158.19
- Axumin (Drug) $150.76
- CONTINENCE CARE (Device) $143.07
- TOROSA (Device) $137.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Salem
Stuart Diamond, Md, MD
Urology — Payments: $18,471
Dr. Alejandra Balen, M.d, M.D
Urology — Payments: $14,486
Bradley Warner, M.d, M.D
Urology — Payments: $10,038
Mr. Noel Defelippo, Md, MD
Urology — Payments: $8,224
Dr. John Mhoon, M.d, M.D
Urology — Payments: $7,907
Mr. Thomas Kingston, Md, MD
Urology — Payments: $6,356